Big Pharma Set To Compete For German Merck's Consumer Health Unit
Executive Summary
German Merck is seeking a buyer or partner for its consumer health unit, which brought in sales of €860m last year and includes big vitamin brands Seven Seas and Neurobion.
You may also be interested in...
GSK And Reckitt Opting Out Of Pfizer's Consumer Business Sale Speaks Volumes
Reckitt and GSK withdraw from negotiating on potential deals for with Pfizer's consumer business, leaving slim chances Pfizer will receive an acceptable offer from other drug firms mentioned as potential suitors for the business, which it has valued at around $20bn. A spin-off could move to the fore.
GSK And Reckitt Opting Out Of Pfizer's Consumer Business Sale Speaks Volumes
Reckitt and GSK withdraw from negotiating on potential deals for with Pfizer's consumer business, leaving slim chances Pfizer will receive an acceptable offer from other drug firms mentioned as potential suitors for the business, which it has valued at around $20bn. A spin-off could move to the fore.
Pharma Q4 Results Preview: Shire, Bayer, Merck KGaA
Potential upheavals in the hemophilia market bring uncertainty for Shire and Bayer, with executives likely to be quizzed on how they can retain market share during upcoming Q4 results calls. Scrip’s final earnings preview highlights the key challenges for large companies reporting at the tail-end of the earnings season.